World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: German Clinical Trials Register
Last refreshed on: 8 April 2024
Main ID:  DRKS00013206
Date of registration: 27/10/2017
Prospective Registration: Yes
Primary sponsor: Medizinische Hochschule Hannover, Institut für Allgemeinmedizin und Palliativmedizin
Public title: Interaction at the end of life in dyads of parents and adult children
Scientific title: Interaction at the end of life in dyads of parents and adult children - Dy@EoL
Date of first enrolment: 22/02/2018
Target sample size: 48
Recruitment status: Complete
URL:  http://drks.de/search/en/trial/DRKS00013206
Study type:  observational
Study design:  Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: supportive care  
Phase: 
Countries of recruitment
Germany
Contacts
Name: Franziska A.    Herbst
Address:  Carl-Neuberg-Str. 1 30625 Hannover Germany
Telephone: +49 511 532 4991
Email: herbst.franziska@mh-hannover.de
Affiliation:  Medizinische Hochschule Hannover, Institut für Allgemeinmedizin und Palliativmedizin
Name: Franziska A.    Herbst
Address:  Carl-Neuberg-Str. 1 30625 Hannover Germany
Telephone: +49 511 532-4991
Email: herbst.franziska@mh-hannover.de
Affiliation:  Medizinische Hochschule Hannover, Institut für Allgemeinmedizin und Palliativmedizin
Key inclusion & exclusion criteria
Inclusion criteria: Inclusion criteria comprise for dyad A) terminally ill patients 18 years of age or older who are seeking palliative or hospice care and who are in contact with at least one living parent and for dyad B) terminally ill parents who are seeking palliative or hospice care and who are in contact with at least one child age 18 years or older.

Dyads of parents and children related through adoption or fosterage will be included.

Having received comprehensive oral and written information about the nature, the content and aim of the study and about study participation, both patient and family member/s provide written informed consent in order to be eligible to participate as a dyad in this project.

If the terminally ill patient is not available to participate in the study, but agrees that the project team contacts an eligible relative for study participation, this relative will be offered study participation. If one of the dyad partners refuses to participate in the study or withdraws consent before, during or after the study, the already collected data of the respective dyad partner may be used in the study or the planned data collection can take place respectively.

Individuals of both sexes and all ethnic backgrounds independent of their main diagnosis may participate in the study.

Exclusion criteria: Exclusion criteria include (1) significant emotional distress during interview, (2) cognitive impairment such as dementia, (3) non-proficiency in German, (4) patient and/or family member does not consent to participate in the study.

Age minimum: 18 Years
Age maximum: None
Gender: All
Health Condition(s) or Problem(s) studied
Terminally ill adult children who receive palliative and/or hospice care and their parents as well as terminally ill parents who receive palliative and/or hospice care and their adult children
Intervention(s)
Group 1: Patients and relatives are interviewed once via face-to-face qualitative semi-strcutured in-depth interviews and assessed via quantitatvie self-report questionnaires.
Primary Outcome(s)
Qualitative and quantitative overview of characteristics of interaction of both dyads

The qualitative overview is obtained by one-time semi-structured in-depth interviews and the quantitative overview is obtained from questionnaires. The following questionnaires are used: 1) demographic questionnaire, 2) Relationship-specific Attachment Scales for Adults, 3) Berlin Social Support Scales, and 4) Graphic Closeness Scale.
Secondary Outcome(s)
Secondary ID(s)
01GY1711
Source(s) of Monetary Support
Bundesministerium für Bildung und Forschung Dienstsitz Berlin
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 04/10/2017
Contact:
ethikkommission@mh-hannover.de
Ethikkommission der Medizinischen Hochschule Hannover
+49-511-5323443
ethikkommission@mh-hannover.de
Results
Results available:
Date Posted:
Date Completed: 30/11/2019
URL: http://drks.de/search/en/trial/DRKS00013206#studyResults
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history